Related Experiment Videos
On evaluating molecular-docking methods for pose prediction and enrichment factors
Hongming Chen1, Paul D Lyne, Fabrizio Giordanetto
1GDECS Computational Chemistry, AstraZeneca R&D, Mölndal, Sweden. hongming.chen@astrazeneca.com
Journal of Chemical Information and Modeling
|January 24, 2006
Summary
Four leading molecular docking programs (FlexX, GOLD, GLIDE, ICM) were evaluated for their ability to reproduce native ligand poses and perform virtual screening. Results show varying performance in docking accuracy and virtual screening enrichment for drug discovery.
Area of Science:
- Computational chemistry
- Drug discovery
- Molecular modeling
Background:
- Commercial molecular docking programs are essential tools in drug discovery for predicting ligand-protein interactions.
- Evaluating the performance of these programs is crucial for optimizing virtual screening strategies.
Purpose of the Study:
- To compare the ligand-docking and virtual-screening capabilities of four leading docking programs: FlexX, GOLD, GLIDE, and ICM.
- To assess their performance in reproducing native ligand conformations and enriching active compounds in virtual screening experiments.
Main Methods:
- The study evaluated 164 high-resolution protein-ligand complexes to assess the programs' ability to reproduce native ligand conformations from SMILES strings.
- Virtual screening was performed using the latest versions of the four programs and their native scoring functions against 12 therapeutic protein targets.
- Performance was measured by the programs' ability to rank target-specific active compounds over decoys and randomly selected compounds.
Main Results:
- The four docking programs exhibited varying performance in reproducing native ligand conformations.
- Virtual screening results showed differences in the programs' ability to enrich active compounds, with some outperforming others in specific target systems.
- Enrichment factors were compared against 3D shape-matching and 2D similarity database search methods.
Conclusions:
- No single docking program consistently outperformed the others across all tested metrics and targets.
- The choice of docking program and scoring function can significantly impact the success of virtual screening campaigns.
- Further optimization and validation of docking programs are needed to enhance their reliability in drug discovery pipelines.